Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1523 results found
2025 ∙ Mohammadi, S. Sisay, M. M. Saraswati, P. W. Osman, A. K. Zuithoff, N. P. A. Weibel, D. Sturkenboom, M. Ahmadizar, F.
COVID-19 vaccine safety studies among special populations: A systematic review and meta-analysis of 120 observational studies and randomized clinical trials
All age groups COVID-19 Safety
Rating:
Critically low
2025 ∙ Blukacz, A. Obach, A. Vasquez, P. Campana, C. Huerta, C. Bernal, Y. Cabieses, B.
Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis
All age groups Low and Middle Income Countries COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Bachmann, M. Gultekin, N. Stanga, Z. Fehr, J. S. Ulgur, I. I. Schlagenhauf, P.
Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Moore, M. Anderson, L. Schiffer, J. T. Matrajt, L. Dimitrov, D.
Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Cao, B. K. Hanifa, R. S. Nguyen, T. P. Postma, M. J. van der Schans, J.
Economic evaluations of vaccines against respiratory infections in adults in Southeast Asia: A systematic review
South-East Asia Western Pacific Adults Older adults Influenza COVID-19 Pneumococcal disease Varicella Pertussis Economic aspects
Rating:
Not applicable
2025 ∙ Phiri, W. W. Kazonga, E. Lubemba, F. Kangwa, G. M. Sakala, L. Banda, M.
Effectiveness of Community-Based Interventions in Reducing Vaccine Hesitancy and Improving COVID-19 Vaccinations Coverage in Developing Countries: A Systematic Review
Adults Older adults Low and Middle Income Countries COVID-19 Coverage
Rating:
Not applicable
2025 ∙ Zhou, G. Dael, N. Verweij, S. Balafas, S. Mubarik, S. Rengerink, K. O. Pasmooij, A. M. G. van Baarle, D. Mol, P. G. M. de Bock, G. H. Hak, E.
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024
Europe Adolescents Adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Azeem, M. Cancemi, P. Mukhtar, F. Marino, S. Peri, E. Di Prima, G. De Caro, V.
Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2025 ∙ Sterian, M. Naganathan, T. Corrin, T. Waddell, L.
Evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition: An updated living systematic review
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2025 ∙ Patel, V. Korsun, M. Cervia, J. S.
EXPRESS: Protective Effects of Booster Dose of SARS-COV-2 Vaccination Against Post-Acute COVID-19 Syndrome: A Systematic Review
Adults Older adults COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
Loading...